Folio · SPXSet Report · Digest
v0.7.0 STABLE · 2026-11-11 · r4

2026-W46 · Nov 9–Nov 15 · Company · Profile · published

Index >>> Company >>> Profile

The Cigna Group (CI) — XLV Health Care · S&P 500 Profile |信諾集團介紹

health-careS&P500xlvxlv-top-25
SPXSet Studio
IN-HOUSE RESEARCH · 站內獨立研究

The Cigna Group (CI) — Business, History & S&P 500 Profile |信諾集團介紹

Cigna company profile · health services — Cigna Healthcare & Evernorth · history · financial snapshot · S&P 500 rank #164 · 信諾集團公司業務歷史財務與標普500地位

中文版 ↓

PROFILE
Market data as of Oct 30, 2026 (frozen benchmark)
Financials: FY2025 (ended Dec 31, 2025)
MARKET CAP
$78.80B
Oct 30, 2026 · Slickcharts (frozen benchmark)
S&P 500 WEIGHT
0.11%
Rank #164 · Oct 30, 2026 (Slickcharts)
FY2025 REVENUE
$274.90B
FY2025 revenue
FY2025 NET INCOME
$5.96B
FY2025 net income

SNAPSHOT

TickerCI (NYSE)
CompanyThe Cigna Group
GICS sector / industryHealth Care (XLV) / Health Care Providers & Services
S&P 500 rank (by weight)#164 · 0.11% (Oct 30, 2026)
Sector rank (by market cap)#23 in Health Care (Oct 30, 2026)
Share price (frozen benchmark)$298.23 (Oct 30, 2026)
HeadquartersBloomfield, Connecticut (900 Cottage Grove Road)
Founded1982 (merger of Connecticut General and INA Corporation; predecessors 1865 and 1792)
CEOBrian Evanko (President and CEO)
Employeesc. 67,700 (2025)
Market cap$78.80B (Oct 30, 2026)

WHAT IT DOES

The Cigna Group is a global health services company providing insurance and related products through two primary divisions: Cigna Healthcare and Evernorth Health Services. Cigna Healthcare provides health benefits and insurance; Evernorth provides pharmacy benefit management and specialty pharmacy services, greatly expanded by its 2018 merger with Express Scripts, mostly sold to health insurance plans and employers. The group serves more than 178 million customer relationships worldwide and operates in more than 30 countries.

The model is premiums plus pharmacy services: Cigna Healthcare collects premiums and manages medical costs, while Evernorth earns fees and spreads on drug benefits. FY2025 revenue was $274.90B, operating income was $8.15B and net income was $5.96B. FY2024 revenue was $247.12B (PitchBook table: $246.148B) and FY2024 net income was $3.43B.

Cigna Corporation was formed in 1982 through the merger of Connecticut General Life Insurance Company (founded 1865) and INA Corporation (founded 1792); the name combines letters from both predecessor companies. In 2023 the company rebranded from Cigna Corporation to The Cigna Group, with Cigna Healthcare and Evernorth Health Services divisions. David Cordani is executive chair; Brian Evanko is president and CEO. In early 2024 Cigna agreed to sell its Medicare Advantage, Supplemental Benefits, Medicare Part D and CareAllies businesses to Health Care Service Corporation (HCSC) in a transaction valued at about $3.7B, which closed in March 2025.

BUSINESS SEGMENTS — FY2025 NET SALES

SegmentRevenueShareYoY
Evernorth Health Services———
Cigna Healthcare———
Segment revenue split not stated in the sources used; units are listed qualitatively, with revenue, share and YoY shown as —. Do not read a split from this table.

HISTORY

YearMilestone
1792INA Corporation predecessor founded
1865Connecticut General Life Insurance Company founded
1982Cigna Corporation formed through the merger of Connecticut General and INA Corporation
2018Merger with Express Scripts greatly expands pharmacy benefit management
2023Company rebrands from Cigna Corporation to The Cigna Group
2025Sale of Medicare Advantage, Supplemental Benefits, Medicare Part D and CareAllies businesses to HCSC closes in March 2025; FY2025 revenue $274.90B

COMPETITIVE POSITION

  • Scale in pharmacy benefits — Evernorth and Express Scripts give bargaining power with drug makers and pharmacies.
  • Integrated model — insurance plus pharmacy services in one group aligns medical and drug costs.
  • Customer breadth — more than 178 million customer relationships worldwide.
  • Competition — UnitedHealth (Optum), CVS Health (Caremark) and Elevance contest the same employer and plan customers.
  • Regulation — pharmacy benefit and health insurance rules are politically contested and change often.

FINANCIAL SNAPSHOT — FY2025

Total revenue$274.90B
Operating income$8.15B
Net income$5.96B
FY2024 revenue (comparative)$247.12B
FY2024 net income (comparative)$3.43B
Total assets$157.92B (FY2025)
Source: The Cigna Group FY2025 results (fiscal year ended Dec 31, 2025). FY2025 revenue is given as $274.90B (Wikipedia) and $274.95B (one quote source); this draft uses $274.90B. FY2024 revenue is $247.12B in one source and $246.148B in the PitchBook table; both are noted, neither is used as the headline figure.

KEY RISKS

  • Medical cost trends — higher utilization and drug prices squeeze insurance margins.
  • PBM regulation — pharmacy benefit manager rules, fees and spread scrutiny.
  • Customer concentration — large employers and plans can move business between PBMs.
  • Government programs — Medicare and Medicaid policy changes affect covered populations.
  • Litigation — health benefits and pharmacy practices face frequent lawsuits.

WHY IT MATTERS FOR THE S&P 500

Cigna is the S&P 500's health-services name: at a 0.11% index weight and #23 in Health Care by market cap, it is the index's main exposure to pharmacy benefit management alongside health insurance.

Its medical cost trend and Evernorth growth are a standing read on American health spending — drug and care costs show up here before they show up in national health accounts.

SOURCES & METHODOLOGY

Market dataSlickcharts S&P 500 by weight (rank, weight, price — Oct 30, 2026 close)
FinancialsThe Cigna Group FY2025 results (fiscal year ended Dec 31, 2025), company profile sources
Sector classificationGICS (Health Care Providers & Services) via the List of S&P 500 companies (Wikipedia)
Library dataSPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information.

Price Chart — 10-Year Monthly Candles

CI

Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com

FINANCIALS

繁體中文版

公司快照

代碼CI(NYSE)
公司The Cigna Group
GICS 板塊/行業醫療保健(XLV)/醫療保健供應商與服務
標普500排名(按權重)#164 · 0.11%(2026 年 10 月 30 日)
板塊內排名(按市值)醫療保健第 #23(2026 年 10 月 30 日)
股價(凍結基準)$298.23(2026 年 10 月 30 日)
總部美國康涅狄格州布盧姆菲爾德(小屋林蔭路 900 號)
成立1982 年(Connecticut General 與 INA Corporation 合併;前身 1865 年與 1792 年)
行政總裁Brian Evanko(總裁兼行政總裁)
員工約 67,700(2025 年)
市值$78.80B(2026 年 10 月 30 日)

業務概覽

信諾集團是一家全球健康服務公司,透過兩個主要部門提供保險及相關產品:信諾醫療保健(Cigna Healthcare)與 Evernorth 健康服務。信諾醫療保健提供健康福利與保險;Evernorth 提供藥房福利管理與專科藥房服務,2018 年與 Express Scripts 合併後大幅擴張,主要售予健康保險計劃與僱主。集團在全球服務逾 1.78 億客戶關係,在 30 多個國家運營。

其模式是保費加藥房服務:信諾醫療保健收取保費並管理醫療成本,Evernorth 則從藥品福利中賺取費用與差價。FY2025 收入為 $274.90B,營業利潤為 $8.15B,淨利潤為 $5.96B。FY2024 收入為 $247.12B(PitchBook 表為 $246.148B),FY2024 淨利潤為 $3.43B。

Cigna Corporation 於 1982 年由 Connecticut General Life Insurance Company(1865 年創立)與 INA Corporation(1792 年創立)合併組成,名稱取自兩家前身公司的字母。2023 年公司由 Cigna Corporation 更名為信諾集團,下設信諾醫療保健與 Evernorth 健康服務部門。David Cordani 為執行董事長,Brian Evanko 為總裁兼行政總裁。2024 年初,信諾同意將其 Medicare Advantage、補充福利、Medicare Part D 與 CareAllies 業務以約 $37 億售予 Health Care Service Corporation(HCSC),交易於 2025 年 3 月完成。

業務板塊 — FY2025

板塊收入佔比同比
Evernorth 健康服務———
信諾醫療保健———
板塊收入拆分未見於所用來源;本表只作定性列示,收入、佔比與同比均記為 —,請勿據此推斷拆分。

歷史沿革

年份里程碑
1792INA Corporation 前身創立
1865Connecticut General Life Insurance Company 創立
1982Connecticut General 與 INA Corporation 合併,組成 Cigna Corporation
2018與 Express Scripts 合併,大幅擴張藥房福利管理
2023公司由 Cigna Corporation 更名為信諾集團
20252025 年 3 月完成向 HCSC 出售 Medicare Advantage、補充福利、Medicare Part D 與 CareAllies 業務;FY2025 收入 $274.90B

競爭地位

  • 藥房福利規模——Evernorth 與 Express Scripts 帶來與藥廠及藥房的議價能力。
  • 綜合模式——同一集團內的保險加藥房服務,令醫療與藥品成本協調一致。
  • 客戶廣度——全球逾 1.78 億客戶關係。
  • 競爭——UnitedHealth(Optum)、CVS Health(Caremark)與 Elevance 爭奪同一批僱主與計劃客戶。
  • 監管——藥房福利與健康保險規則在政治上備受爭議,經常變化。

財務快照 — FY2025

總收入$274.90B
營業利潤$8.15B
淨利潤$5.96B
FY2024 收入(比較)$247.12B
FY2024 淨利潤(比較)$3.43B
總資產$157.92B(FY2025)
來源:信諾集團 FY2025 業績(財政年度截至 2025 年 12 月 31 日)。FY2025 收入有 $274.90B(Wikipedia)與 $274.95B(一報價來源)兩種表述;本稿採用 $274.90B。FY2024 收入在一來源為 $247.12B,在 PitchBook 表為 $246.148B;兩者均作註明,均不用作標題數字。

主要風險

  • 醫療成本趨勢——使用率上升與藥價上漲壓縮保險利潤率。
  • 藥房福利管理監管——藥房福利管理規則、費用與差價審查。
  • 客戶集中——大型僱主與計劃可在藥房福利管理商之間轉移業務。
  • 政府計劃——Medicare 與 Medicaid 政策變化影響覆蓋人群。
  • 訴訟——健康福利與藥房做法經常面臨訴訟。

對標普500的重要性

信諾是標普500的健康服務標的:指數權重 0.11%、醫療保健板塊市值第 #23,是指數對藥房福利管理連同健康保險的主要敞口。

其醫療成本趨勢與 Evernorth 增長,是美國健康支出的常設讀數——藥品與護理成本往往先在此反映,再體現於全國健康賬目。

來源與方法

市場數據Slickcharts 標普500權重榜(排名、權重、價格——2026 年 10 月 30 日收盤)
財務信諾集團 FY2025 業績(財政年度截至 2025 年 12 月 31 日)、公司簡介來源
板塊分類GICS(醫療保健供應商與服務),據 S&P 500 公司清單(Wikipedia)
圖庫數據SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。 SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。

10年股價K線圖(月K)

CI

來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份) · SPXSet.com

財報

SPXSet Studio

SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。

SPXSet · Company Library · CI
Data as of Oct 30, 2026 · Financials FY2025 (10-K) · Market data Oct 2026
Previous · DoorDash, Inc. (DASH) — XLY Consumer Discretionary · S&P 500 Profile |DoorDash介紹Next · Elevance Health, Inc. (ELV) — XLV Health Care · S&P 500 Profile |信諾健康公司介紹

Entered 2026-10-31 04:34 · updated 2026-11-14 23:08 · rev 6